Published:
Number of shares and votes in Active Biotech
The number of shares and votes in Active
Biotech has changed as a
consequence of the recently completed rights issue with pre-emptive
rights for the shareholders.
Today, the last trading day of the month, there are in total
64,052,238 shares and votes in Active Biotech.
Lund, June 30, 2009
Active Biotech AB (publ)
For further information, please contact:
Hans Kolam, CFO
Tel: +46 (0)46 19 20 44
E-mail: hans.kolam@activebiotech.com
About Active Biotech
Active Biotech AB (NASDAQ OMX NORDIC: ACTI) is a biotechnology
company with focus on autoimmune/inflammatory diseases and cancer.
Projects in pivotal phase are laquinimod, an orally administered
small molecule with unique immunomodulatory properties for the
treatment of multiple sclerosis, as well as ANYARA for use in cancer
targeted therapy, primarily of renal cancer. Further key projects in
clinical development comprise the three orally administered compounds
TASQ for prostate cancer, 57-57 for SLE and RhuDex(TM) for RA. Please
visit www.activebiotech.com for more information.
Active Biotech AB
PO Box 724, SE-220 07 Lund
Sweden
Tel: +46 (0)46-19 20 00
Fax: +46 (0)46-19 11 00
Active Biotech is required under the Financial Instruments Trading
Act to make the information in this press release public. The
information was submitted for publication at 08:30 am CET on June 30,
2009.
This announcement was originally distributed by Hugin. The issuer is
solely responsible for the content of this announcement.
Copyright © Hugin AS 2009. All rights reserved.
Copyright © 2009, MarketWire
Copyright © 2009, NewsBlaze,
Daily NewsTags: ,Pharmaceuticals and Biotech:Drugs, Chemicals:SpecialtyChemicals, ,,LUND, SWEDEN
_ _
Breast Cancer News
Search News
Daily News
